Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Open letter to the members of the GOLD committee].
Le groupe Pulmonaria, Quanjer PH, Enright PL, Stocks J, Ruppel G, Swanney MP, Crapo RO, Pedersen OF, Falaschetti E, Schouten JP, Jensen RL; ANZSRS : Australian and New Zealand Society of Respiratory; ARTP : Association for Respiratory Technology and Physiology; CAHAG : COPD and Astma Huisartsen Advies Groep (COPD and Asthma GP Advisory Group); SKL : Dutch Paediatric Repiratory Society; Education for Health, Warwick, UK; National Respiratory Training Center, Virginia, US; NHG : Nederlands Huisartsen Genootschap (Dutch Society of GPs); NVALT : Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose (Dutch Thoracic Society); NVLA : Nederlandse Vereniging Longfunctie Analisten (Dutch Society of Respiratory Technicians); PCRS-UK : Primary Care Respiratory Society UK; Société de Physiologie; SPLF : Société de pneumologie de langue franc¸aise; SSMG : Société scientifique de médecine générale; WONCA: World Organization of Family Doctors. Le groupe Pulmonaria, et al. Among authors: falaschetti e. Rev Mal Respir. 2010 Nov;27(9):1003-7. doi: 10.1016/j.rmr.2010.09.007. Epub 2010 Oct 8. Rev Mal Respir. 2010. PMID: 21111268 French. No abstract available.
Open letter: the need to change the method for defining mild airway obstruction.
Quanjer PH, Enright PL, Miller MR, Stocks J, Ruppel G, Swanney MP, Crapo RO, Pedersen OF, Falaschetti E, Schouten JP; Pulmonaria Group. Quanjer PH, et al. Among authors: falaschetti e. Prim Care Respir J. 2010 Sep;19(3):288-91. doi: 10.4104/pcrj.2010.00052. Prim Care Respir J. 2010. PMID: 20818478 Free PMC article. No abstract available.
Diagnosis of COPD.
Falaschetti E, Swanney MP, Crapo RO, Hankinson JL, Jensen RL, Pedersen OF, Quanjer PH, Ruppel GL, Schouten JP. Falaschetti E, et al. Thorax. 2007 Oct;62(10):924-5; author reply 925. Thorax. 2007. PMID: 17909194 Free PMC article. No abstract available.
Changes in the FEV₁/FVC ratio during childhood and adolescence: an intercontinental study.
Quanjer PH, Stanojevic S, Stocks J, Hall GL, Prasad KV, Cole TJ, Rosenthal M, Perez-Padilla R, Hankinson JL, Falaschetti E, Golshan M, Brunekreef B, Al-Rawas O, Kühr J, Trabelsi Y, Ip MS; Global Lungs Initiative. Quanjer PH, et al. Among authors: falaschetti e. Eur Respir J. 2010 Dec;36(6):1391-9. doi: 10.1183/09031936.00164109. Epub 2010 Mar 29. Eur Respir J. 2010. PMID: 20351026 Free article.
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
Kawano-Dourado L, Kulkarni T, Ryerson CJ, Rivera-Ortega P, Baldi BG, Chaudhuri N, Funke-Chambour M, Hoffmann-Vold AM, Johannson KA, Khor YH, Montesi SB, Piccari L, Prosch H, Molina-Molina M, Sellares Torres J, Bauer-Ventura I, Rajan S, Jacob J, Richards D, Spencer LG, Wendelberger B, Jensen T, Quintana M, Kreuter M, Gordon AC, Martinez FJ, Kaminski N, Cornelius V, Lewis R, Adams W, Jenkins G; REMAP-ILD consortium. Kawano-Dourado L, et al. Thorax. 2024 Mar 6:thorax-2023-221148. doi: 10.1136/thorax-2023-221148. Online ahead of print. Thorax. 2024. PMID: 38448221 Free article. Review.
A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol.
Barbera M, Lehtisalo J, Perera D, Aspö M, Cross M, De Jager Loots CA, Falaschetti E, Friel N, Luchsinger JA, Gavelin HM, Peltonen M, Price G, Neely AS, Thunborg C, Tuomilehto J, Mangialasche F, Middleton L, Ngandu T, Solomon A, Kivipelto M; MET-FINGER study team. Barbera M, et al. Among authors: falaschetti e. Alzheimers Res Ther. 2024 Jan 31;16(1):23. doi: 10.1186/s13195-023-01355-x. Alzheimers Res Ther. 2024. PMID: 38297399 Free PMC article.
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial.
Kanagaratnam P, McCready J, Tayebjee M, Shepherd E, Sasikaran T, Todd D, Johnson N, Kyriacou A, Hayat S, Hobson NA, Mann I, Balasubramaniam R, Whinnett Z, Earley M, Petkar S, Veasey R, Kirubakaran S, Coyle C, Kim MY, Lim PB, O'Neill J, Davies DW, Peters NS, Babalis D, Linton N, Falaschetti E, Tanner M, Shah J, Poulter N. Kanagaratnam P, et al. Among authors: falaschetti e. Europace. 2023 Mar 30;25(3):863-872. doi: 10.1093/europace/euac253. Europace. 2023. PMID: 36576323 Free PMC article. Clinical Trial.
Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial.
Whinnett ZI, Shun-Shin MJ, Tanner M, Foley P, Chandrasekaran B, Moore P, Adhya S, Qureshi N, Muthumala A, Lane R, Rinaldi A, Agarwal S, Leyva F, Behar J, Bassi S, Ng A, Scott P, Prasad R, Swinburn J, Tomson J, Sethi A, Shah J, Lim PB, Kyriacou A, Thomas D, Chuen J, Kamdar R, Kanagaratnam P, Mariveles M, Burden L, March K, Howard JP, Arnold A, Vijayaraman P, Stegemann B, Johnson N, Falaschetti E, Francis DP, Cleland JGF, Keene D. Whinnett ZI, et al. Among authors: falaschetti e. Eur J Heart Fail. 2023 Feb;25(2):274-283. doi: 10.1002/ejhf.2736. Eur J Heart Fail. 2023. PMID: 36404397 Free PMC article. Clinical Trial.
The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial.
Lee MJ, Collins S, Babalis D, Johnson N, Falaschetti E, Prevost AT, Ashraf A, Jacob M, Cole T, Hurley L, Pace M, Ogbe A, Khan M, Zacharopoulou P, Brown H, Sutherland E, Box H, Fox J, Deeks S, Horowitz J, Nussenzweig MC, Caskey M, Frater J, Fidler S. Lee MJ, et al. Among authors: falaschetti e. Trials. 2022 Apr 5;23(1):263. doi: 10.1186/s13063-022-06151-w. Trials. 2022. PMID: 35382844 Free PMC article.
49 results